Handelsbanken Fonder’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74M | Sell |
49,800
-7,700
| -13% | -$423K | 0.01% | 554 |
|
|
2025
Q1 | $4.07M | Buy |
57,500
+8,600
| +18% | +$608K | 0.02% | 456 |
|
|
2024
Q4 | $3.21M | Sell |
48,900
-75,122
| -61% | -$4.94M | 0.01% | 531 |
|
|
2024
Q3 | $8.72M | Buy |
124,022
+2,456
| +2% | +$173K | 0.03% | 368 |
|
|
2024
Q2 | $10M | Buy |
121,566
+24,754
| +26% | +$2.04M | 0.04% | 337 |
|
|
2024
Q1 | $8.46M | Buy |
96,812
+6,762
| +8% | +$591K | 0.04% | 379 |
|
|
2023
Q4 | $8.68M | Sell |
90,050
-1,705
| -2% | -$164K | 0.04% | 362 |
|
|
2023
Q3 | $8.12M | Buy |
91,755
+1,593
| +2% | +$141K | 0.05% | 346 |
|
|
2023
Q2 | $7.82M | Buy |
90,162
+12,451
| +16% | +$1.08M | 0.04% | 365 |
|
|
2023
Q1 | $7.56M | Buy |
77,711
+2,408
| +3% | +$234K | 0.04% | 361 |
|
|
2022
Q4 | $7.79M | Buy |
75,303
+5,044
| +7% | +$522K | 0.05% | 358 |
|
|
2022
Q3 | $5.96M | Hold |
70,259
| – | – | 0.04% | 378 |
|
|
2022
Q2 | $5.82M | Sell |
70,259
-232,242
| -77% | -$19.2M | 0.04% | 403 |
|
|
2022
Q1 | $23.3M | Sell |
302,501
-3,850
| -1% | -$297K | 0.13% | 168 |
|
|
2021
Q4 | $27.1M | Buy |
306,351
+85,338
| +39% | +$7.54M | 0.13% | 171 |
|
|
2021
Q3 | $17.1M | Buy |
221,013
+4,443
| +2% | +$343K | 0.09% | 230 |
|
|
2021
Q2 | $18.1M | Buy |
216,570
+173,799
| +406% | +$14.5M | 0.09% | 229 |
|
|
2021
Q1 | $3.23M | Sell |
42,771
-420
| -1% | -$31.7K | 0.02% | 525 |
|
|
2020
Q4 | $3.79M | Sell |
43,191
-98
| -0.2% | -$8.59K | 0.02% | 470 |
|
|
2020
Q3 | $3.29M | Buy |
43,289
+1,600
| +4% | +$122K | 0.02% | 443 |
|
|
2020
Q2 | $5.14M | Buy |
+41,689
| New | +$5.14M | 0.04% | 336 |
|
|
2016
Q4 | – | Sell |
-16,500
| Closed | -$1.53M | – | 161 |
|
|
2016
Q3 | $1.53M | Hold |
16,500
| – | – | 0.04% | 141 |
|
|
2016
Q2 | $1.28M | Sell |
16,500
-5,000
| -23% | -$389K | 0.05% | 119 |
|
|
2016
Q1 | $1.77M | Sell |
21,500
-17,989
| -46% | -$1.48M | 0.08% | 117 |
|
|
2015
Q4 | $4.14M | Buy |
+39,489
| New | +$4.14M | 0.08% | 215 |
|